FDA accepts Merck application for lung cancer combo therapy | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/11/fda-accepts-merck-application-for-lung-cancer-combo-therapy/

(Reuters) – Merck & Co on Tuesday said the FDA agreed to a speedy review of its application to combine its immunotherapy drug Keytruda with chemotherapy as an initial treatment for advanced lung cancer, potentially giving it a major leg up in the competition for the largest cancer market. http://internationalnewslive.com/fda-accepts-merck-application-for-lung-cancer-combo-therapy/